Ran Li

Ran Li

Auto-generated profile, based on publicly available information

Ran Li

Department of Hematology The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital Nanjing China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Journal of Affective Disorders
Verified
Journal Article
Closed access
ZYZhi-Ying Yao
Zhi-Ying Yao
TWTao Wang
Tao Wang
YYYao-Kun Yu
Yao-Kun Yu
RLRan Li
Ran Li
XSXiao Sang
Xiao Sang
CJCun-xian Jia
Cun-xian Jia

1 March 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YYYichu Yang
Yichu Yang
YLYiye Li
Yiye Li
RLRan Li
Ran Li
ZWZhang Wang
Zhang Wang
Introduction: The toxicity of arsenic is widely recognized globally, mainly harming human health by polluting water, soil, and food. However, its formulations can also be used for the clinical treatment of diseases such as leukemia and tumors. Arsenic has been used as a drug in China for over 2,400 years, with examples such as the arsenic-containing drug realgar mentioned in Shennong’s Herbal Classic. We have reviewed references on arsenic over the past thirty years and found that research has mainly focused on clinical, pharmacological, and toxicological aspects.Results and Discussion: The finding showed that in clinical practice, arsenic trioxide is mainly used in combination with all-trans retinoic acid (ATRA) at a dose of 10 mg/d for the treatment of acute promyelocytic leukemia (APL); realgar can be used to treat acute promyelocytic leukemia, myelodysplastic syndrome, and lymphoma. In terms of pharmacology, arsenic mainly exerts anti-tumor effects. The dosage range of the action is 0.01–80 μmol/L, and the concentration of arsenic in most studies does not exceed 20 μmol/L. The pharmacological effects of realgar include antiviral activity, inhibition of overactivated lactate dehydrogenase, and resistance to malaria parasites. In terms of toxicity, arsenic is toxic to multiple systems in a dose-dependent manner. For example, 5 μmol/L sodium arsenite can induce liver oxidative damage and promote the expression of pro-inflammatory factors, and 15 μmol/L sodium arsenite induces myocardial injury; when the concentration is higher, it is more likely to cause toxic damage.

25 July 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
PJPeng Jin
Peng Jin
QJQiqi Jin
Qiqi Jin
XWXiaoling Wang
Xiaoling Wang
MZMing Zhao
Ming Zhao
FDFangyi Dong
Fangyi Dong
JLJunmin Li
Junmin Li
Purpose: The molecular complexity of acute myeloid leukemia (AML) presents a considerable challenge to implementation of clinical genetic testing for accurate risk stratification. Identification of better biomarkers therefore remains a high priority to enable improving established stratification and guiding risk-adapted therapy decisions. Experimental Design: We systematically integrated and analyzed the genome-wide CRISPR-Cas9 data from more than 1,000 in vitro and in vivo knockout screens to identify the AML-specific fitness genes. A prognostic fitness score was developed using the sparse regression analysis in a training cohort of 618 cases and validated in five publicly available independent cohorts (n = 1,570) and our RJAML cohort (n = 157) with matched RNA sequencing and targeted gene sequencing performed. Results: A total of 280 genes were identified as AML fitness genes and a 16-gene AML fitness (AFG16) score was further generated and displayed highly prognostic power in more than 2,300 patients with AML. The AFG16 score was able to distill downstream consequences of several genetic abnormalities and can substantially improve the European LeukemiaNet classification. The multi-omics data from the RJAML cohort further demonstrated its clinical applicability. Patients with high AFG16 scores had significantly poor response to induction chemotherapy. Ex vivo drug screening indicated that patients with high AFG16 scores were more sensitive to the cell-cycle inhibitors flavopiridol and SNS-032, and exhibited strongly activated cell-cycle signaling. Conclusions: Our findings demonstrated the utility of the AFG16 score as a powerful tool for better risk stratification and selecting patients most likely to benefit from chemotherapy and alternative experimental therapies.

11 January 2019 in Journal of International Students
Verified
Journal Article
Open access
PDF file
YCYu Chen
Yu Chen
RLRan Li
Ran Li
Linda Serra HagedornLinda Serra Hagedorn
Linda Serra Hagedorn
This study developed statistical models to forecast international undergraduate student enrollment at a Midwest university. The authors constructed a SARIMA (Seasonal Autoregressive Integrated Moving Average) model with input variables to estimate future enrollment. The SARIMA model reflected enrollment patterns by semester through highlighting seasonality. Further, authors added input variables such as visa policy changes, the rapid increase of Chinese undergraduate enrollment, and tuition rate into the model estimation. The visa policy change and the increase of Chinese undergraduate enrollment were significant predictors of international undergraduate enrollment. The effect of tuition rates was significant but minimal in magnitude. Findings of this study generate significant implications for policy, enrollment management, and student services for international students.

3 June 2022 in The FASEB Journal
Verified
Journal Article
Open access
RLRan Li
Ran Li
XWXiaolu Wu
Xiaolu Wu
PZPing Zhao
Ping Zhao
KXKai Xue
Kai Xue
LJLi Junmin
Li Junmin
Histone deacetylase 11 (HDAC11) is aberrantly expressed in many types of cancer, and such abnormalities are associated with tumor immunity and heterogeneous clinical outcomes. Here, we explore the prognostic value and immunological function of HDAC11 across 33 cancer types. We observe HDAC11 is aberrantly expressed in 25 cancer types and positively or negatively associated with prognosis in different cancers. HDAC11 played a protective prognostic role in KIRP, KIRC, LGG, PCPG, READ, and UVM, which was contrary to the conventional opinion that HDAC11 was an oncogenic gene. Moreover, HDAC11 is negatively associated with tumor immune components, most immune checkpoint genes, and key cytokine expression. HDAC11 is correlated with tumor mutational burden in 11 cancer types and with microsatellite instability in 9 cancer types, suggesting HDAC11 may affect a patient's response to immune checkpoint inhibitor (ICI) therapy. In addition, HDAC11 is negatively correlated with the drug sensitivity of oxaliplatin, carmustine, ifosfamide, imexon, lomustine, and BN‐2629, indicating the potential synergy between HDAC11 inhibitors and these anti‐tumor drugs. In vitro assays indicate that HDAC11 inhibitor SIS17 combined with oxaliplatin shows a synergistic cytotoxic role in K562 cells while SIS17 has an antagonistic effect on the cytotoxic role of oxaliplatin in 769P cells. HDAC11 is also associated with hallmark pathways, including epithelial mesenchymal transition, IL‑6/JAK/STAT3, and allograft rejection pathways. Overall, we provide clues regarding the key role of HDAC11 in multiple cancers.

1 December 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
JCJintao Cao
Jintao Cao
SSShuai Sun
Shuai Sun
RMRui Min
Rui Min
RLRan Li
Ran Li
XFXingyu Fan
Xingyu Fan
NLNan Li
Nan Li
Purpose: The aim of this study was to explore potential gene therapy targets for triple-negative breast cancer (TNBC). Patients and Methods: Three gene expression profiles (GSE64790, GSE62931, and GSE38959) from the Gene Expression Omnibus (GEO) database were analyzed. The GEO2R analysis tool was used to screen for differentially expressed genes (DEGs) between TNBC and normal tissues, followed by Gene Ontology functional annotation and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of the DEGs. The protein–protein interaction network of DEGs was visualized using Metascape to identify the core genes. Subsequently, transcriptional data for the core genes in patients with breast cancer were investigated in the ONCOMINE database. Kaplan–Meier survival analysis was used to evaluate the prognostic value of core gene expression levels in patients with TNBC. Finally, the clinicopathological and long-term follow-up data of 39 patients with TNBC were retrospectively analyzed at the First Affiliated Hospital of the Bengbu Medical College between January 2014 and July 2020. Immunohistochemistry was used to evaluate the expression and subcellular localization of CCNB2 in TNBC tissues. Results: A total of 66 DEGs were identified between TNBC and normal tissues, including 33 upregulated and 33 downregulated genes in TNBC. Furthermore, a potential protein complex was identified for five core genes. The high expression of these core genes, especially the overexpression of CCNB2, was correlated with a poor prognosis of patients with TNBC. The CCNB2 protein was expressed in the cytoplasm, and its expression was significantly higher in TNBC tissues than that in the adjacent nontumor tissues. Overall survival of patients was significantly correlated with the expression of CCNB2 (p < 0.05). Conclusion: CCNB2 may play a crucial role in the development of TNBC and has the potential to be used as a prognostic biomarker for TNBC.